Euroapi

Euroapi, established in 2021, is a prominent pharmaceutical manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and offering Contract Development and Manufacturing Organization (CDMO) services for innovative molecule development. The company boasts a portfolio of approximately 200 products, leveraging scientific excellence and industrial expertise to deliver high-quality pharmaceutical solutions. Listed on Euronext Paris, Euroapi is committed to creating sustainable active ingredient solutions for global healthcare partners.

Operating with a workforce of 1,000 to 5,000 employees, Euroapi manages six advanced manufacturing sites strategically located across Europe, including facilities in France, Italy, Germany, Hungary, and the United Kingdom. This extensive operational footprint enables the company to supply its high-quality APIs to a diverse customer base in over 80 countries worldwide. For insights into the company's leadership and operational structure, you can Meet Euroapi's team.

Euroapi's financial performance is robust, with reported revenue of $1.0B. The company recently secured $474 million in debt funding, with Sanofi as a key investor, underscoring its financial stability and growth potential. Euroapi's dedication to rigorous quality standards and its broad geographic reach solidify its position as a key player in the global pharmaceutical supply chain. Further details on its financial standing are available via Explore financial highlights.